bullish
Venus Medtech (启明医疗) Pre-IPO: Thoughts on Valuation
555 Views11 Nov 2019 16:58
Venus Medtech (Hangzhou) is a dominant player in the heart valve replacement devices market in China. The company started pre-marketing for a USD...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Peijia Medical (沛嘉医疗) Pre-IPO: Reminiscence of Venus Medtech?18 Feb 2020
- Venus Medtech (启明医疗) IPO Trading: Allocation and Buy-Level09 Dec 2019
- Venus Medtech (启明医疗) IPO: Valuation Still OK at the High End26 Nov 2019
- Venus Medtech (启明医疗) IPO: Technical Comparison of VenusA-Valve and Peers11 Sep 2019
- Venus Medtech (启明医疗) IPO: Has the Elements for a Hot Healthcare Deal21 Aug 2019
x